Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
WEBFeb 26, 2024 · The standing of C4 Therapeutics among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations,...
New Forecasts: Here's What Analysts Think The Future Holds For C4 ...
WEBFeb 27, 2024 · It's clear from the latest estimates that C4 Therapeutics' rate of growth is expected to accelerate meaningfully, with the forecast 28% annualised revenue growth to the end of 2024 noticeably...
C4 Therapeutics, Inc. (CCCC) Latest Stock News & Headlines
WEBGet the latest C4 Therapeutics, Inc. (CCCC) stock news and headlines to help you in your trading and investing decisions.
C4 Therapeutics Announces 2024 Priorities and Extended Cash …
WEBJan 9, 2024 · C4 Therapeutics, Inc. Multiple 2024 Clinical Updates Expected, Including Data from the Ongoing CFT7455 and CFT1946 Phase 1 Dose Escalation Trials. Prioritization of CFT7455, CFT1946,...
Key Takeaways From C4 Therapeutics Analyst Ratings
WEBMay 9, 2024 · In the assessment of 12-month price targets, analysts unveil insights for C4 Therapeutics, presenting an average target of $10.75, a high estimate of $14.00, and a low estimate of $8.00.
C4 Therapeutics Announces 2024 Priorities and Extended Cash …
WEBJan 9, 2024 · Key 2024 priorities include advancing the CFT7455 and CFT1946 clinical programs to value-inflection milestones, supporting CFT8919 Phase 1 development in China by partner Betta Pharmaceuticals, delivering on three discovery collaborations and progressing a streamlined internal discovery effort.
Latest news about C4 Therapeutics, Inc. - MarketScreener
WEBSep 6, 2024 · C4 Therapeutics, Inc.: News, information and stories for C4 Therapeutics, Inc. | Nasdaq: CCCC | Nasdaq
Wall Street Analysts See a 197.7% Upside in C4 Therapeutics ... - Nasdaq
WEBJan 1, 2024 · Shares of C4 Therapeutics, Inc. (CCCC) have gained 253.1% over the past four weeks to close the last trading session at $5.65, but there could still be a solid upside left in the stock if...
C4 Therapeutics Inc (CCCC) Stock Price & News - Google Finance
WEBGet the latest C4 Therapeutics Inc (CCCC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
C4 Therapeutics (CCCC) Soars on Oncology Deal With Merck
WEBDec 13, 2023 · C4 Therapeutics (CCCC) inks an agreement with Merck to discover and develop degrader-antibody conjugates with a focus on one oncology target. Shares rise on the same.
- Some results have been removed
Skip to content